Pivotal bioVenture Partners Investment Advisor as of March 31, 2025
Portfolio Holdings for Pivotal bioVenture Partners Investment Advisor
Pivotal bioVenture Partners Investment Advisor holds 11 positions in its portfolio as reported in the March 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Oculis Holding Ordinary Shares (OCS) | 35.4 | $44M | 2.3M | 19.03 | |
| Arcutis Biotherapeutics (ARQT) | 26.8 | $33M | 2.1M | 15.64 | |
| Vaxcyte (PCVX) | 21.7 | $27M | 711k | 37.76 | |
| Zenas Biopharma (ZBIO) | 4.7 | $5.8M | 737k | 7.90 | |
| Inozyme Pharma (INZY) | 3.3 | $4.1M | 4.5M | 0.91 | |
| Recursion Pharmaceuticals In Cl A (RXRX) | 2.5 | $3.2M | 596k | 5.29 | |
| Bioage Labs (BIOA) | 2.0 | $2.5M | 653k | 3.76 | |
| Rallybio Corp (RLYB) | 1.3 | $1.6M | 2.4M | 0.65 | |
| Vigil Neuroscience (VIGL) | 0.8 | $998k | 561k | 1.78 | |
| Io Biotech (IOBT) | 0.8 | $942k | 864k | 1.09 | |
| Bolt Biotherapeutics | 0.6 | $757k | 1.9M | 0.40 |
